Insider trades
Jennifer L. Good, Director of Rhythm Pharmaceuticals RYTM, has filed 0 purchases and 11 sales on the open market. The latest trade was on 06/24.
Jennifer L. Good
Director
- Company
- Rhythm Pharmaceuticals RYTM
- First filing
- 23/02/16
- Trades
- 69 trades
- Buys / sales
- 0 / 11
- 12-month net buying
- No record
- Last trade
- 06/24
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 25/03/21 | 25/03/25 | 5,263 sh | $6.58 | $34,630.54 | −2.4% | |
| Open-market sale10b5-1 plan | 24/09/17 | 24/09/19 | 31,751 sh | $52.40 | $1,663,752.4 | −91.4% | |
| Open-market sale10b5-1 plan | 24/09/09 | 24/09/11 | 37,241 sh | $50.45 | $1,878,808.45 | −92.5% | |
TRVI | Open-market sale | 24/09/06–24/09/09 | 24/09/09 | 6,059 sh2 trades | $3.03avg. | $18,377.17 | −2.8% |
TRVI | Open-market sale | 24/09/03–24/09/05 | 24/09/05 | 55,121 sh3 trades | $3.09avg. | $170,090.35 | −20.5% |
| Open-market sale10b5-1 plan | 24/08/26 | 24/08/28 | 14,508 sh | $50.01 | $725,545.08 | −82.9% | |
| Open-market sale | 24/05/20 | 24/05/22 | 25,037 sh | $2.86 | $71,605.82 | −10.5% | |
| Open-market sale | 24/05/10 | 24/05/14 | 4,578 sh | $2.90 | $13,276.2 | −2.1% |
